Breaking News, Collaborations & Alliances

Syngene, Amgen Extend R&D Collaboration

Syngene’s dedicated R&D center will continue to conduct drug discovery & development projects as part of Amgen’s global R&D program.

Author Image

By: Charlie Sternberg

Associate Editor

Syngene International, an integrated research, development and manufacturing services company, has extended its long-standing multi-discipline research collaboration with Amgen Inc, a leading biotechnology company.   The contract is currently extended until the end of 2026 and its scope includes integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical develo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters